Some functional-medicine literature discusses a possible link between intestinal permeability, sometimes called leaky gut, and autoimmune thyroid disease, but this remains an area of research rather than settled clinical practice
however, compounded medications are not FDA-approved and do not undergo safety, effectiveness, or manufacturing review
As the chart shows, GLP-1s can only be prescribed for chronic weight management associated solely with obesity or a combination of obesity and glycemic control in people with type 2 diabetes
I am looking forward to when the Tirzepatide kicks in
Am J Physiol Endocrinol Metab 290(6):E1118-1123
GLP-1 medications address biological factors like hunger cues and insulin function, but they dont eliminate the need for sustainable healthy habits